Hedgehog signaling and therapeutics in pancreatic cancer

Carcinogenesis

Volumn 32, Issue 4, 2011, Pages 445-451

  Kelleher, Fergal C ^a,b  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO N [4 CHLORO 3 (2 PYRIDINYL)PHENYL] 4 METHANESULFONYLBENZAMIDE; ANTINEOPLASTIC AGENT; CD24 ANTIGEN; CYCLOPAMINE; ERLOTINIB; GEMCITABINE; HERMES ANTIGEN; IPI 926; PACLITAXEL; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; CANCER INHIBITION; CANCER RESISTANCE; CANCER STEM CELL; CANCER SURVIVAL; CARCINOGENESIS; DISEASE ASSOCIATION; ECTODERM; EPITHELIUM CELL; GENE TARGETING; GENETIC ANALYSIS; HUMAN; IMMUNOPHENOTYPING; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MEDLINE; METASTASIS; MISSENSE MUTATION; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; TUMOR MICROENVIRONMENT; TUMOR VASCULARIZATION;

ADENOCARCINOMA; ANILIDES; ANIMALS; CLINICAL TRIALS AS TOPIC; HEDGEHOG PROTEINS; HUMANS; NEOPLASTIC STEM CELLS; PANCREATIC NEOPLASMS; PYRIDINES; SIGNAL TRANSDUCTION;

EID: 79953702542     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgq280     Document Type: Review

References (47)

1. Developmental genetics and birth defects. (2007) Chapter 14, P441. Genetics in Medicine. 7th edn. Saunders, Philadelphia, PA.
2. Ruiz, I and Altaba, A. (2006) Hedgehog-Gli signaling in Human Disease. Molecular Biology Intelligence Unit. Springer, New York, NY.
3. Siu, L.L. (2008) Abstract A55: a first-in-human, phase I study of an oral hedgehog pathway antagonist, BMS-833923 (XL139), in subjects with advanced or metastatic solid tumors. Mol. Cancer Ther., 8, A55 doi:10.1158/1535-7163.TARG-09-A55.
4. Romer, J.T. et al. (2004) Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell, 3, 229-240.
5. Berman, D.M. et al. (2003) Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature, 425, 846-851.
6. Evangelista, M. et al. (2006) The hedgehog signaling pathway in cancer. Clin. Cancer Res., 12, p5924-p5928.
7. Merchant, A.A. et al. (2010) Targeting hedgehog-a cancer stem cell pathway. Clin. Cancer Res., 16, p3130-p3150 Review article.
8. Ji, Z. et al. (2007) Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells. J. Biol. Chem., 282, 14048-14055.
9. Kimura, H. et al. (2008) Transient inhibition of the Hedgehog pathway in young mice causes permanent defects in bone structure. Cancer Cell, 13, 249-260.
10. Dierks, C. et al. (2008) Expansion of Bcr-Abl-positive leukemic stem cells is dependent on Hedgehog pathway activation. Cancer Cell, 14, 238-249.
11. Von Hoff, D.D. et al. (2008) Inhibition of the hedgehog pathway in advanced basal-cell carcinoma. N. Engl. J. Med., 361, 1164-1172.
12. Rudin, C.M. et al. (2009) Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. N. Engl. J. Med., 361, 1173-1178.
13. Dellovade, T. et al. (2006) The hedgehog pathway and neurological disorders. Annu. Rev. Neurosci., 29, 539-563.
14. Rubin, L.L. et al. (2006) Targeting the hedgehog pathway in cancer. Nat. Rev. Drug Discov., 12, 1026-1033 Review.
15. García de Marcos, J.A. et al. (2009) Basal cell nevus syndrome: clinical and genetic diagnosis. Oral Maxillofac. Surg., 4, 225-230.
16. Yauch, R.L. et al. (2009) Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science, 326, 572-574.
17. Talpaz, M. (2006) Dasatinib in imatinib-resistant Philadelphia Chromosome-Positive Leukemias. N. Engl. J. Med., 354, 2531-2541.
18. Choi, Y.L. et al. (2010) EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors. N. Engl. J. Med., 363, 1734-1739.
19. Lauth, M. et al. (2007) Inhibition of GLI-mediated transcription and tumor cell growth by small-molecule antagonists. Proc. Natl Acad. Sci. USA, 104, 8455-8460.
20. Thayer, S.P. et al. (2003) Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis. Nature, 425, 851-856.
21. Bailey, J.M. et al. (2008) Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin. Cancer Res., 14, 5995-6600.
22. Olive, K.P. et al. (2009) Inhibition of Hedgehog signalling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science, 324, 1457-1461.
23. Feldmann, G. et al. (2008) Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut, 57, 1420-1430.
24. Li, C. et al. (2007) Identification of pancreatic cancer stem cells. Cancer Res., 67, 1030-1037.
25. Hermann, P.C. et al. (2007) Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell, 1, 313-323.
26. Hawes, R.H. et al. (2000) A multispeciality approach to approach to the diagnosis and management of pancreatic cancer. Am. J. Gastroenterol., 95, 17-31.
27. Jones, S. et al. (2008) Core signalling pathways in human pancreatic cancers revealed by global genomic analyses. Science, 321, 1801-1806.
28. Bailey, J.M. et al. (2009) Sonic hedgehog paracrine signalling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene, 28, 3513-3525.
29. Morton, J.P. et al. (2007) Sonic hedgehog acts at multiple stages during pancreatic tumourigenesis. Proc. Natl Acad. Sci. USA, 104, 5103-5108.
30. Tian, H. et al. (2009) Hedgehog signalling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc. Natl Acad. Sci. USA, 106, 4254-4259.
31. Oettle, H. et al. (2007) Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA, 297, 267-277.
32. Feldmann, G. et al. (2007) Blockade of hedgehog signalling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res., 67, 2187-2196.
33. Willett, C.G. et al. (2005) Review article. J. Clin. Oncol., 23, 4538-4544.
34. Krzyanowska, M.K. et al. (2003) Treatment of locally advanced pancreatic cancer in the Real World: population-based practices and effectiveness. J. Clin. Oncol., 21, 3409-3414.
35. Martin, R.C. 2nd et al. (2009) Arterial and venous resection for pancreatic adenocarcinoma: operative and long-term outcomes. Arch. Surg., 144, 154-159.
36. Garber, K. (2010) Stromal depletion goes on trial in pancreatic cancer. J. Natl Cancer Inst., 102, 448-450.
37. Walter, K. et al. (2010) Overexpression of smoothened activates the sonic hedgehog signaling pathway in pancreatic cancer-associated fibroblasts. Clin. Cancer Res., 16, 1781-1789.
38. Moore, M.J. et al. (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J. Clin. Oncol., 25, 1960.
39. Mimeault, M. et al. (2006) Cytotoxic effects induced by a combination of cyclopamine and gefitinib, the selective hedgehog and epidermal growth factor receptor signalling inhibitors, in prostate cancer cells. Int. J. Cancer, 118, 1022-1031.
40. Zhou, B.B. et al. (2009) Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat. Rev. Drug Discov., 8, 806-823.
41. Riobó, N.A. et al. (2006) Phosphoinositide 3-kinase and Akt are essential for sonic hedgehog signalling. Proc. Natl Acad. Sci. USA, 103, 4505-4510.
42. Ji, Z. et al. (2007) Oncogenic KRAS activates hedgehog signalling pathway in pancreatic cancer cells. J. Biol. Chem., 282, 14048-14055.
43. Lauth, M. et al. (2010) DYRK1B-dependent autocrine-to-paracrine shift of Hedgehog signaling by mutant RAS. Nat. Struct. Mol. Biol., 17, 718-725.
44. Yauch, R.L. et al. (2008) A paracrine requirement for hedgehog signalling in cancer. Nature, 455, 406-410.
45. Nakamura, K. et al. (2010) Hedgehog promotes neovascularisation in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells. PLoS One, 5, e8824.
46. Bailey, J.M. et al. (2009) Sonic hedgehog paracrine signalling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene, 28, 3513-3525.
47. Tian, H. et al. (2009) Hedgehog signalling is restricted to the stromal compartment during pancreatic carcinogenesis. Proc. Natl Acad. Sci. USA, 106, 4254-4259.